ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Pediatric rheumatology"

  • Abstract Number: 0658 • ACR Convergence 2021

    ACCORD: A Novel Rheumatology Transition Clinic Structure for Adolescent and Young Adult Patients with Childhood Onset Rheumatic Disease

    Rebecca Overbury1, Kelly Huynh2, Tracy Frech1, John Bohnsack1 and Aimee Hersh1, 1University of Utah, Salt Lake City, UT, 2Intermountain Health Care, Salt Lake City, UT

    Background/Purpose: The transition of health care from Pediatric to Adult providers for adolescents and young adults with childhood onset rheumatic disease continues to be associated…
  • Abstract Number: 0783 • ACR Convergence 2021

    Transmission Disequilibrium Testing Meets Next Generation Sequencing: Applying TDT to Whole Genome Data in Childhood-Onset Systemic Lupus Erythematosus

    Kathleen Vazzana1, Anthony Musolf2, Joan Bailey-Wilson3, Zuoming Deng3, Mariana Kaplan3 and Laura Lewandowski2, 1National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)/Children's National Hospital, Washington, DC, 2NIAMS, NIH, Rockville, MD, 3National Institutes of Health, Bethesda, MD

    Background/Purpose: Systemic lupus erythematosus (SLE) is a systemic autoimmune disorder that is more severe in children than adults. Due to aggressive disease in childhood-onset SLE…
  • Abstract Number: 1110 • ACR Convergence 2021

    Cryopyrin-associated Periodic Syndromes: GOSH and National Amyloidosis Centre Experience

    Ovgu Kul Cinar1, Charalampia Papadopoulou2, Amber Putland1, Karen Wynne1, Helen J Lachmann3, Despina Eleftheriou4 and Paul A. Brogan4, 1Great Ormond Street Hospital NHS Trust, London, United Kingdom, 2UCL Institute of Child Health, and Great Ormond Street Hospital NHS Foundation Trust, Infection, Immunology, and Rheumatology, London, United Kingdom, 3National Amyloidosis Centre, Royal Free Campus, UCL Medical School, London, United Kingdom, 4Great Ormond Street Hospital NHS Trust, UCL GOS Institute of Child Health, Department of Infection, Immunity & Inflammation, London, United Kingdom

    Background/Purpose: CAPS is a rare, heterogenous inflammasomopathy associated with gain-of-function mutations in NLRP3 that encodes cryopyrin. Mutations in NLRP3 result in excessive IL-1ß production that…
  • Abstract Number: 1626 • ACR Convergence 2021

    Use of Total Hip Arthroplasty in Patients Under 21 Years Old: A U.S. Population Analysis

    J. Alex Gibbons1, Cynthia Kahlenberg1, Deanna Jannat-Khah1, Susan Goodman1, Lisa Mandl1, Peter Sculco1, Stuart Goodman2, Mark Figgie1 and Bella Mehta3, 1Hospital for Special Surgery, New York, NY, 2Stanford University, Stanford, CA, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: Total hip arthroplasty (THA) is a treatment option for young patients with severe hip pathology due to congenital, developmental, rheumatologic, traumatic, and other acquired…
  • Abstract Number: 0702 • ACR Convergence 2021

    Performance of Commercial Autoantibody Testing in Comparison to Recognized Gold Standards in Myositis Autoantibody Testing

    Sarvar Nazir1, Lisa Rider2, Ira Targoff3, Stanley Naides4, Andrew Mammen5, Steven Greenberg6 and Adam Schiffenbauer5, 1NIEHS, NIH, Bethesda, MD, 2NIEHS, NIH, Garrett Park, MD, 3Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Self, Dana Point, CA, 5National Institutes of Health, Bethesda, MD, 6Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: The idiopathic inflammatory myopathies (IIM) are a heterogenous group of autoimmune conditions. The presence of myositis-specific autoantibodies (MSAs) and myositis-associated autoantibodies (MAAs) in patients…
  • Abstract Number: 0784 • ACR Convergence 2021

    Use of EuroLupus Cyclophosphamide Dosing for the Treatment of Lupus Nephritis in Childhood-Onset Systemic Lupus Erythematosus in North America

    Laura Cannon1, Scott Wenderfer2, Laura Lewandowski3, Jennifer Cooper4, Beatrice Goilav5, Andrea Knight6, Aimee Hersh7, Stacy Ardoin8 and Rebecca Sadun1, 1Duke University, Durham, NC, 2Baylor College of Medicine, Houston, TX, 3NIAMS, NIH, Rockville, MD, 4University of Colorado/Children's Hospital Colorado, Denver, CO, 5Children's Hospital at Montefiore, Bronx, NY, 6Hospital for Sick Children, Toronto, ON, Canada, 7University of Utah, Salt Lake City, UT, 8Nationwide Children's Hospital, Columbus, OH

    Background/Purpose: Childhood-onset systemic lupus erythematosus (cSLE) has higher rates of lupus nephritis (LN) than adult-onset SLE, often requiring intensive immunosuppression. This study examined North American…
  • Abstract Number: 1159 • ACR Convergence 2021

    Improving Healthcare Transition Implementation: Recommendations from Young Patients with Rheumatic Conditions

    Courtney Wells1, Peter Chira2, Dana Guglielmo3, Stacy Ardoin4, Katelyn Melcher5, Meghan Trimble6 and Kristine Carandang7, 1University of Wisconsin-River Falls, White Bear Lake, MN, 2Pediatric Rheumatology, University of California San Diego, Rady Children’s Hospital, San Diego, CA, 3Student, Atlanta, GA, 4Nationwide Children's Hospital, Columbus, OH, 5Patient Partner, Ankeny, IA, 6Patient Partner, Minneapolis, MN, 7Independent, San Diego, CA

    Background/Purpose: Implementation of structured healthcare transition processes remains elusive for most US rheumatology clinics (Johnson et al., 2021). Although research studies have proposed models and…
  • Abstract Number: 1627 • ACR Convergence 2021

    Long Term Follow-Up of Patients with Childhood-Onset Lupus Nephritis After Transition to Adult Care

    Dahima Cintrón1, Suheiry Márquez1 and Luis Vilá2, 1University of Puerto Rico Medical Sciences Campus, San Juan, PR, 2University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico

    Background/Purpose: Approximately 20% of patients with systemic lupus erythematosus (SLE) are diagnosed before 18 years of age. Pediatric patients have a worse disease course when…
  • Abstract Number: 0167 • ACR Convergence 2021

    Reliability of a Novel Pediatric Joint-Specific Scoring System for the Elbow, Wrist and Finger Joints

    Patricia Vega-Fernandez1, Ysabella Esteban2, Edward Oberle3, Jean-Philippe Proulx-Gauthier4, Matthew Clark5, Hulya Bukulmez6, Susan Shenoi7, Akaluck Thatayatikom8, Heather Benham9, Emily Brunner10, Leandra Woolnough8, Michael Henrickson1, Laura Ballenger3, Deidre DeRanieri11, Sarah Hoffmann12, Ginger Janow13, Mekibib Altaye14, Amy Cassedy2, Johannes Roth15 and Tracy Ting1, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Cincinnati Children's Hospital and Medical Center, Cincinnati, OH, 3Nationwide Children's Hospital, Columbus, OH, 4CHU de Quebec - Universite Laval, Québec City, QC, Canada, 5Vanderbilt University Medical Center, Nashville, TN, 6MetroHealth Medical Center, Case Western Reserve, Pepper Pike, OH, 7Seattle Children's Hospital, Seattle, WA, 8University of Florida, Gainesville, FL, 9Scottish RIte Hospital, North Richland Hills, TX, 10Geisinger, Bloomsburg, PA, 11Lurie Children's Hospital, Chicago, IL, 12Children's Hospital of Richmond at VCU, Richmond, VA, 13Joseph M. Sanzari Children's Hospital at Hackensack Meridian Health, Glen Rock, NJ, 14Cincinnati Children's Hospital, Cincinnati, OH, 15University of Ottawa, Ottawa, ON, Canada

    Background/Purpose: The clinical decision-making process in pediatric arthritis lacks an objective, reliable bedside imaging tool. Musculoskeletal ultrasound (MSUS) is increasingly being utilized in children. In…
  • Abstract Number: 0764 • ACR Convergence 2021

    Patients with Juvenile Systemic Sclerosis Have a Distinct Pattern of Organ Involvement: Results from the Juvenile Systemic Sclerosis Inception Cohort

    Ivan Foeldvari1, Jens Klotsche2, Ozgur Kasapcopur3, Amra Adrovic4, Kathryn Torok5, Maria Terreri6, Ana Paula Sakamoto7, Flavio Sztajnbok8, Brian Feldman9, Valda Stanevicha10, Jordi Anton11, Raju Khubchandani12, Ekaterina Alexeeva13, Sindhu Johnson14, Maria Martha Katsicas15, Sujata Sawhney16, Vanessa Smith17, Simone Appenzeller18, Tadej Avcin19, Mikhail Kostik20, Thomas Lehman21, Edoardo Marrani22, Dieneke Schonenberg-Meinema23, Walter Alberto Sifuentes-Giraldo24, Natalia Vasquez-Canizares25, Mahesh Janarthanan26, Hana Malcova27, Monika Moll28, Dana Nemcova29, Anjali Patwardhan30, Maria José Santos31, cristina battagliotti32, Lillemor Berntson33, Blanca Elena Rios Gomes Bica34, Jürgen Brunner35, Rolando Cimaz36, Patricia Costa Reis37, Despina Eleftheriou38, Liora Harel39, Gerd Horneff40, Daniela Kaiser41, Tilmann Kallinich42, Dragana Lazarevic43, Kirsten Minden2, Susan Nielsen44, Farzana Nuruzzaman45, Siri Opsahl Hetlevik46, Yosef Uziel47 and Nicola Helmus48, 1Hamburger Zentrum fuer Kinder- und Jugendrheumatologie, Hamburg, Germany, 2German Rheumatism Research Center, Berlin, Germany, 3Istanbul University-Cerrahpasa, Cerrahpasa Medical School, İstanbul, Turkey, 4Cerrahpasa Medical School, Istanbul, Turkey, 5University of Pittsburgh, Pittsburgh, PA, 6UNIFESP, São Paulo, Brazil, 7Federal University of So Paulo (UNIFESP), São Paulo, Brazil, 8UFRJ/UERJ, Rio de Janeiro, Brazil, 9The Hospital for Sick Children, Toronto, ON, Canada, 10Paediatric Rheumatology International Trials Organisation (PRINTO), Riga, Latvia, 11Hospital Sant Joan de Deu, University of Barcelona, Barcelona, Spain, 12Jaslok Hospital and Research Center, Mumbai, India, 13Scientific Center of Children Health of RAMS, Moscow, Russia, 14University of Toronto, Toronto, ON, Canada, 15Hospital de Pediatria J.P Garrahan, Buenos Aires, Argentina, 16Pediatric Rheumatology Department, Institute of Child Health, Sir Gangarm Hospital, New Delhi, India, 17Department of Rheumatology and Internal Medicine, Ghent University Hospital, Ghent, Belgium, 18Hospital das Clínicas da Universidade Estadual de Campinas, Campinas, Brazil, 19University Medical Center Ljubljana, Ljubljana, Slovenia, 20Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russia, 21Hospital for Special Surgery, New York, NY, 22University of Florence, Florence, Italy, 23Emma Children’s Hospital, Amsterdam, Netherlands, 24Hospital Universitario Ramón y Cajal, Madrid, Spain, 25Children’s Hospital at Montefiore, Bronx, NY, 26Sri Ramachandra University, Chennai, India, 27Motol University Hospital, Prague, Czech Republic, 28University Tuebingen, Tübingen, Germany, 29Charles University, Prague, Czech Republic, 30University of Missouri-Columbia, Columbia, MO, 31Rheumatology Department, Hospital Garcia de Orta, Almada, Portugal, 32Hospital de Niños Dr Orlando Alassia, Santa Fe, Argentina, 33Uppsala University, Uppsala, Sweden, 34Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil, 35Medical University Innsbruck, Innsbruck, Austria, 36ASST Gaetano Pini-CTO, Università degli Studi di Milano, Milan, Italy, 37Hospital de Santa Maria, Lisbon, Portugal, 38Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom, 39Scheiders Children Medical Center of Israel, Petah-Tiqva, Israel, 40Paediatric Rheumatology International Trials Organisation (PRINTO), Sankt Augustin, Germany, 41Luzerner Kantonsspital, Kinderspital, Luzern, Switzerland, 42Charité University Medicine, Nuremberg, Germany, 43Dept of Pediatric Rheumatology and Immunology Clinical Center Nis, Nis, Serbia, 44Rigshospitalet, Copenhagen, Denmark, 45Stony Brook Children's Hospital, Stony Brook, NY, 46Oslo University Hospital, Oslo, Norway, 47Meir Medical Center, Kfar Saba, Israel, 48Hamburg Centre for Pediatric and Adolescence Rheumatology, Hamburg, Germany

    Background/Purpose: Juvenile systemic sclerosis (jSSc) is a rare disease with a prevalence of around 3 in 1,000,000 children. To better capture the clinical manifestations of…
  • Abstract Number: 0956 • ACR Convergence 2021

    Racial Disparities in Renal Outcomes over Time Among Hospitalized Children with SLE and Effects of Hospital Minority Composition

    Joyce Chang1, Cora Sears2, Veronica Torres3 and Mary Beth Son1, 1Boston Children's Hospital, Brookline, MA, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3Temple University, Bucks County, PA

    Background/Purpose: Racial and ethnic minorities are disproportionately affected by pediatric-onset SLE and have worse outcomes compared to their white counterparts. With ongoing advances in pediatric…
  • Abstract Number: 1174 • ACR Convergence 2021

    Teaching and Reproducibility of a Pediatric Musculoskeletal Ultrasound Scoring System

    Ysabella Esteban1, Jackeline Rodriguez-Smith2, Marie Tominna2, Arthur Meyers2, Michael Henrickson2, Amy Cassedy2, Tracy Ting2 and Patricia Vega-Fernandez2, 1Cincinnati Children's Hospital and Medical Center, Cincinnati, OH, 2Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Localized musculoskeletal ultrasound (MSUS) examination is used in adult rheumatology clinics and has been shown to be a valid and feasible method for assessing…
  • Abstract Number: 1628 • ACR Convergence 2021

    Reproductive Health Knowledge Gaps, Needs, and Barriers Identified by Pediatric Rheumatology Providers

    Kimberly Hays1, Catherine Lavallee2, Brittany Huynh3, Tova Ronis4, Barbara Edelheit5, Kathryn Cook6, Veronica Mruk7 and Cuoghi Edens8, 1Penn State Health, Hershey, PA, 2Virginia Tech Carilion School of Medicine, Roanoke, VA, 3Riley Hospital for Children at Indiana University, Indianapolis, IN, 4Children's National Hospital, Washington, MD, 5CT Children's Medical Center, Hartford, CT, 6Akron Childrens Hospital, Copley, OH, 7Ohio State University / Nationwide Children's Hospital, Columbus, OH, 8University of Chicago, Chicago, IL

    Background/Purpose: Rheumatic diseases and their treatments present unique challenges to sexual and reproductive health (SRH) issues facing patients and clinicians. Despite this, literature in the…
  • Abstract Number: 0175 • ACR Convergence 2021

    Correlation of Subclinical Synovitis with Juvenile Idiopathic Arthritis Outcome Measurements

    Patricia Vega-Fernandez1, Edward Oberle2, Michael Henrickson1, Jennifer Huggins1, Mekibib Altaye3, Amy Cassedy4, Johannes Roth5 and Tracy Ting1, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Nationwide Children's Hospital, Columbus, OH, 3Cincinnati Children's Hospital, Cincinnati, OH, 4Cincinnati Children's Hospital and Medical Center, Cincinnati, OH, 5University of Ottawa, Ottawa, ON, Canada

    Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is the most common rheumatologic disease of childhood. Active joint count (AJC) is one of the key JIA Core Set…
  • Abstract Number: 0765 • ACR Convergence 2021

    Male Juvenile Systemic Sclerosis Patients Have More Severe Disease: Results from the International Juvenile Scleroderma Inception Cohort

    Ivan Foeldvari1, Jens Klotsche2, Ozgur Kasapcopur3, Amra Adrovic4, Kathryn Torok5, Maria Terreri6, Ana Paula Sakamoto7, Flavio Sztajnbok8, Brian Feldman9, Valda Stanevicha10, Jordi Anton11, Raju Khubchandani12, Ekaterina Alexeeva13, Sindhu Johnson14, Maria Martha Katsicas15, Sujata Sawhney16, Vanessa Smith17, Simone Appenzeller18, Tadej Avcin19, Mikhail Kostik20, Thomas Lehman21, Edoardo Marrani22, Dieneke Schonenberg-Meinema23, Walter Alberto Sifuentes-Giraldo24, Natalia Vasquez-Canizares25, Mahesh Janarthanan26, Hana Malcova27, Monika Moll28, Dana Nemcova29, Anjali Patwardhan30, Maria José Santos31, cristina battagliotti32, Lillemor Berntson33, Blanca Elena Rios Gomes Bica34, Jürgen Brunner35, Rolando Cimaz36, Patricia Costa Reis37, Despina Eleftheriou38, Liora Harel39, Gerd Horneff40, Daniela Kaiser41, Tilmann Kallinich42, Dragana Lazarevic43, Kirsten Minden2, Susan Nielsen44, Farzana Nuruzzaman45, Siri Opsahl Hetlevik46, Yosef Uziel47 and Nicola Helmus48, 1Hamburger Zentrum fuer Kinder- und Jugendrheumatologie, Hamburg, Germany, 2German Rheumatism Research Center, Berlin, Germany, 3Istanbul University-Cerrahpasa, Cerrahpasa Medical School, İstanbul, Turkey, 4Cerrahpasa Medical School, Istanbul, Turkey, 5University of Pittsburgh, Pittsburgh, PA, 6UNIFESP, São Paulo, Brazil, 7Federal University of So Paulo (UNIFESP), São Paulo, Brazil, 8UFRJ/UERJ, Rio de Janeiro, Brazil, 9The Hospital for Sick Children, Toronto, ON, Canada, 10Paediatric Rheumatology International Trials Organisation (PRINTO), Riga, Latvia, 11Hospital Sant Joan de Deu, University of Barcelona, Barcelona, Spain, 12Jaslok Hospital and Research Center, Mumbai, India, 13Scientific Center of Children Health of RAMS, Moscow, Russia, 14University of Toronto, Toronto, ON, Canada, 15Hospital de Pediatria J.P Garrahan, Buenos Aires, Argentina, 16Pediatric Rheumatology Department, Institute of Child Health, Sir Gangarm Hospital, New Delhi, India, 17Department of Rheumatology and Internal Medicine, Ghent University Hospital, Ghent, Belgium, 18Hospital das Clínicas da Universidade Estadual de Campinas, Campinas, Brazil, 19University Medical Center Ljubljana, Ljubljana, Slovenia, 20Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russia, 21Hospital for Special Surgery, New York, NY, 22University of Florence, Florence, Italy, 23Emma Children’s Hospital, Amsterdam, Netherlands, 24Hospital Universitario Ramón y Cajal, Madrid, Spain, 25Children’s Hospital at Montefiore, Bronx, NY, 26Sri Ramachandra University, Chennai, India, 27Motol University Hospital, Prague, Czech Republic, 28University Tuebingen, Tübingen, Germany, 29Charles University, Prague, Czech Republic, 30University of Missouri-Columbia, Columbia, MO, 31Rheumatology Department, Hospital Garcia de Orta, Almada, Portugal, 32Hospital de Niños Dr Orlando Alassia, Santa Fe, Argentina, 33Uppsala University, Uppsala, Sweden, 34Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil, 35Medical University Innsbruck, Innsbruck, Austria, 36ASST Gaetano Pini-CTO, Università degli Studi di Milano, Milan, Italy, 37Hospital de Santa Maria, Lisbon, Portugal, 38Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom, 39Scheiders Children Medical Center of Israel, Petah-Tiqva, Israel, 40Paediatric Rheumatology International Trials Organisation (PRINTO), Sankt Augustin, Germany, 41Luzerner Kantonsspital, Kinderspital, Luzern, Switzerland, 42Charité University Medicine, Nuremberg, Germany, 43Dept of Pediatric Rheumatology and Immunology Clinical Center Nis, Nis, Serbia, 44Rigshospitalet, Copenhagen, Denmark, 45Stony Brook Children's Hospital, Stony Brook, NY, 46Oslo University Hospital, Oslo, Norway, 47Meir Medical Center, Kfar Saba, Israel, 48Hamburg Centre for Pediatric and Adolescence Rheumatology, Hamburg, Germany

    Background/Purpose: Juvenile systemic sclerosis (jSSc) is a rare disease with a prevalence of around 3 in 1,000,000 children. To better capture the clinical manifestations of…
  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 52
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology